# Study of 18FET PET in Functional Pituitary Adenomas With Indeterminate MRI Findings

> **NCT07360548** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University Hospital, Lille** · enrollment: 30 (estimated)

## Conditions studied

- Functional Pituitary Adenomas

## Interventions

- **DRUG:** fluoroethyl-L tyrosine (18F)

## Key facts

- **NCT ID:** NCT07360548
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2030-09
- **Final completion:** 2030-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07360548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07360548, "Study of 18FET PET in Functional Pituitary Adenomas With Indeterminate MRI Findings". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07360548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*